Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) EV-to-EBITDA : 6.76 (As of Jun. 16, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Macro Group Pharmaceuticals (Macro Capital) Co's enterprise value is E£1,119.9 Mil. Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was E£165.6 Mil. Therefore, Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA for today is 6.76.

The historical rank and industry rank for Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA or its related term are showing as below:

CAI:MCRO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.56 Med: 7.05 Max: 12.39
Current: 6.76

During the past 3 years, the highest EV-to-EBITDA of Macro Group Pharmaceuticals (Macro Capital) Co was 12.39. The lowest was 3.56. And the median was 7.05.

CAI:MCRO's EV-to-EBITDA is ranked better than
73.23% of 1558 companies
in the Consumer Packaged Goods industry
Industry Median: 10.76 vs CAI:MCRO: 6.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-16), Macro Group Pharmaceuticals (Macro Capital) Co's stock price is E£2.01. Macro Group Pharmaceuticals (Macro Capital) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was E£0.190. Therefore, Macro Group Pharmaceuticals (Macro Capital) Co's PE Ratio for today is 10.58.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-EBITDA Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-EBITDA Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data

Trend

Dec20

Dec21

Dec22

EV-to-EBITDA

7.32

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial						7.63	6.85	8.92	7.32	8.81

Competitive Comparison of Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA falls into.

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-EBITDA Calculation

Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	1119.873	/	165.624
	=	6.76

Macro Group Pharmaceuticals (Macro Capital) Co's current Enterprise Value is E£1,119.9 Mil.
Macro Group Pharmaceuticals (Macro Capital) Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£165.6 Mil.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) EV-to-EBITDA Explanation

Macro Group Pharmaceuticals (Macro Capital) Co's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	2.01	/	0.190
	=	10.58

Macro Group Pharmaceuticals (Macro Capital) Co's share price for today is E£2.01.
Macro Group Pharmaceuticals (Macro Capital) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.190.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Macro Group Pharmaceuticals (Macro Capital) Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY

Website

https://www.macro-egy.com

Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.